A Study of Optical Fusion Trans-Perineal Grid

Enrolling by invitation · Not applicable

Conditions studied: Prostate Biopsy

In brief

The purpose of this research is to evaluate a new needle guide grid utilizing Clear Guide SCENERGY - MR with a grid embedded with VisiMARKER II to autoregister and target the prostate aiding in needle placement positioning. The proceduralist can utilize this technology to find the best needle path to target within the pelvis.

Key facts

Study ID

NCT05573048

Run by

Mayo Clinic

People needed

20

Starts

2022-10-04

Expected to finish

2026-12-01

Last updated by the study team

2026-01-14

Who can join

Age: 45 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Scheduled for a MR guided biopsy or ablation.
• One, two, or three tumor suspicious regions identified on multiparametric MRI.
• Tolerance for anesthesia/sedation.
• Ability to give informed consent.

You may not qualify if…

• Presence of any condition (e.g., metal implant, shrapnel) not compatible with MRI.
• History of other primary non-skin malignancy within previous three years.

Where it is running

• Mayo Clinic Minnesota — Rochester, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.